212 related articles for article (PubMed ID: 33590415)
1. Toxic milk mice models of Wilson's disease.
Hadrian K; Przybyłkowski A
Mol Biol Rep; 2021 Feb; 48(2):1903-1914. PubMed ID: 33590415
[TBL] [Abstract][Full Text] [Related]
2. In
Sharma Y; Liu J; Kristian KE; Follenzi A; Gupta S
Gene Expr; 2018 Dec; 19(1):15-24. PubMed ID: 30029699
[TBL] [Abstract][Full Text] [Related]
3. Activation of HIF-1 signaling ameliorates liver steatosis in zebrafish atp7b deficiency (Wilson's disease) models.
Mi X; Li Z; Yan J; Li Y; Zheng J; Zhuang Z; Yang W; Gong L; Shi J
Biochim Biophys Acta Mol Basis Dis; 2020 Oct; 1866(10):165842. PubMed ID: 32446740
[TBL] [Abstract][Full Text] [Related]
4. DPM-1001 decreased copper levels and ameliorated deficits in a mouse model of Wilson's disease.
Krishnan N; Felice C; Rivera K; Pappin DJ; Tonks NK
Genes Dev; 2018 Jul; 32(13-14):944-952. PubMed ID: 29945887
[TBL] [Abstract][Full Text] [Related]
5. Long-Term Correction of Copper Metabolism in Wilson's Disease Mice with AAV8 Vector Delivering Truncated ATP7B.
Leng Y; Li P; Zhou L; Xiao L; Liu Y; Zheng Z; Qin F; Hao Q; Xu H; Yao S; Dong B
Hum Gene Ther; 2019 Dec; 30(12):1494-1504. PubMed ID: 31668086
[TBL] [Abstract][Full Text] [Related]
6. Neuroinflammatory and behavioural changes in the Atp7B mutant mouse model of Wilson's disease.
Terwel D; Löschmann YN; Schmidt HH; Schöler HR; Cantz T; Heneka MT
J Neurochem; 2011 Jul; 118(1):105-12. PubMed ID: 21517843
[TBL] [Abstract][Full Text] [Related]
7. ATP7B gene therapy of autologous reprogrammed hepatocytes alleviates copper accumulation in a mouse model of Wilson's disease.
Cai H; Cheng X; Wang XP
Hepatology; 2022 Oct; 76(4):1046-1057. PubMed ID: 35340061
[TBL] [Abstract][Full Text] [Related]
8. Animal models of Wilson disease.
Medici V; Huster D
Handb Clin Neurol; 2017; 142():57-70. PubMed ID: 28433110
[TBL] [Abstract][Full Text] [Related]
9. Epidemiology of Wilson's Disease and Pathogenic Variants of the
Ovchinnikova EV; Garbuz MM; Ovchinnikova AA; Kumeiko VV
Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38397079
[TBL] [Abstract][Full Text] [Related]
10. Functional iron deficiency in toxic milk mutant mice (tx-J) despite high hepatic ferroportin: a critical role of decreased GPI-ceruloplasmin expression in liver macrophages.
Jończy A; Lipiński P; Ogórek M; Starzyński RR; Krzysztofik D; Bednarz A; Krzeptowski W; Szudzik M; Haberkiewicz O; Miłoń A; Grzmil P; Lenartowicz M
Metallomics; 2019 Jun; 11(6):1079-1092. PubMed ID: 31011744
[TBL] [Abstract][Full Text] [Related]
11. Metallothionein is elevated in liver and duodenum of Atp7b
Zhang CC; Volkmann M; Tuma S; Stremmel W; Merle U
Biometals; 2018 Aug; 31(4):617-625. PubMed ID: 29732486
[TBL] [Abstract][Full Text] [Related]
12. Heterozygous tx mice have an increased sensitivity to copper loading: implications for Wilson's disease carriers.
Cheah DM; Deal YJ; Wright PF; Buck NE; Chow CW; Mercer JF; Allen KJ
Biometals; 2007 Oct; 20(5):751-7. PubMed ID: 17136311
[TBL] [Abstract][Full Text] [Related]
13. Age-dependent changes of cerebral copper metabolism in Atp7b
Xie F; Xi Y; Pascual JM; Muzik O; Peng F
Metab Brain Dis; 2017 Jun; 32(3):717-726. PubMed ID: 28130615
[TBL] [Abstract][Full Text] [Related]
14. Laser ablation inductively coupled plasma mass spectrometry imaging of metals in experimental and clinical Wilson's disease.
Boaru SG; Merle U; Uerlings R; Zimmermann A; Flechtenmacher C; Willheim C; Eder E; Ferenci P; Stremmel W; Weiskirchen R
J Cell Mol Med; 2015 Apr; 19(4):806-14. PubMed ID: 25704483
[TBL] [Abstract][Full Text] [Related]
15. Activation of Autophagy, Observed in Liver Tissues From Patients With Wilson Disease and From ATP7B-Deficient Animals, Protects Hepatocytes From Copper-Induced Apoptosis.
Polishchuk EV; Merolla A; Lichtmannegger J; Romano A; Indrieri A; Ilyechova EY; Concilli M; De Cegli R; Crispino R; Mariniello M; Petruzzelli R; Ranucci G; Iorio R; Pietrocola F; Einer C; Borchard S; Zibert A; Schmidt HH; Di Schiavi E; Puchkova LV; Franco B; Kroemer G; Zischka H; Polishchuk RS
Gastroenterology; 2019 Mar; 156(4):1173-1189.e5. PubMed ID: 30452922
[TBL] [Abstract][Full Text] [Related]
16. A Gene Therapy Approach to Improve Copper Metabolism and Prevent Liver Damage in a Mouse Model of Wilson Disease.
Greig JA; Nordin JML; Smith MK; Ashley SN; Draper C; Zhu Y; Bell P; Buza EL; Wilson JM
Hum Gene Ther Clin Dev; 2019 Mar; 30(1):29-39. PubMed ID: 30693797
[TBL] [Abstract][Full Text] [Related]
17. Cell therapy to remove excess copper in Wilson's disease.
Gupta S
Ann N Y Acad Sci; 2014 May; 1315(1):70-80. PubMed ID: 24820353
[TBL] [Abstract][Full Text] [Related]
18. Epigenetic changes of the thioredoxin system in the tx-j mouse model and in patients with Wilson disease.
Mordaunt CE; Shibata NM; Kieffer DA; Czlonkowska A; Litwin T; Weiss KH; Gotthardt DN; Olson K; Wei D; Cooper S; Wan YY; Ali MR; LaSalle JM; Medici V
Hum Mol Genet; 2018 Nov; 27(22):3854-3869. PubMed ID: 30010856
[TBL] [Abstract][Full Text] [Related]
19. [The onset of psychiatric disorders and Wilson's disease].
Benhamla T; Tirouche YD; Abaoub-Germain A; Theodore F
Encephale; 2007 Dec; 33(6):924-32. PubMed ID: 18789784
[TBL] [Abstract][Full Text] [Related]
20. ATP7B Mutation Detection and Pathogenicity Analysis: One Atypical Case of Wilson's Disease with Adrenocortical Insufficiency.
Liu M; Jin M; Chen X; Wan B; Guo Y; Sheng M; Chen L; Zhao L; Huang D; Li Y
J Mol Neurosci; 2018 Jan; 64(1):20-28. PubMed ID: 29181760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
